Insiders who reported open-market trades in the last 12 months at the companies Faraz Ali files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Faraz Ali is a corporate insider, tracked as Chief Executive Officer, Director of Tenaya Therapeutics, Inc. (TNYA). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Faraz Ali submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Faraz Ali been buying or selling stock?
Recorded transactions: 0 open-market purchases and 12 open-market sales ($50K) across all tracked filings.
Faraz Ali is Chief Executive Officer, Director of Tenaya Therapeutics, Inc. (TNYA). 7 SEC Form 4 filings on record going back to 2025, most recently on 12 September 2026. Most recent open-market trade: sold $5K of TNYA on 18 August 2026. Lifetime open-market sales: $50K.
Recent transactions
14
The latest 14 SEC Form 4 transactions reported by Faraz Ali.
InsiderAlpha's records for Faraz Ali go back to 2025: 7 primary Form 4 filings, an average of 3.5 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
